Evidence map›Paper›PMID 26839058›Full record

ArticleNature communications2016

Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders.

Takanobu Nakazawa, Ryota Hashimoto, Kazuto Sakoori, Yuki Sugaya, Asami Tanimura, Yuki Hashimotodani, Kazutaka Ohi, Hidenaga Yamamori, Yuka Yasuda, Satomi Umeda-Yano and 15 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. ZebrafishFrontiers in molecular neuroscience · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 1 country.

Takanobu NakazawaDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Ryota HashimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.ORCID http://orcid.org/0000-0002-5941-4238
Kazuto SakooriDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Yuki SugayaDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Asami TanimuraDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Yuki HashimotodaniDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Kazutaka OhiDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Hidenaga YamamoriDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Yuka YasudaDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Satomi Umeda-YanoDepartment of Molecular Neuropsychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Yuji KiyamaDivision of Neuronal Network, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Kohtarou KonnoDepartment of Anatomy, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
Takeshi InoueDivision of Oncology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Kazumasa YokoyamaDivision of Oncology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Takafumi InoueDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo 162-8480, Japan.
Shusuke NumataDepartment of Psychiatry, Course of Integrated Brain Sciences, School of Medicine, University of Tokushima, Tokushima 770-8503, Japan.
Tohru OhnumaDepartment of Psychiatry, Juntendo University School of Medicine, Tokyo 113-0033, Japan.
Nakao IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.ORCID http://orcid.org/0000-0003-3189-6076
Norio OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya 461-8673, Japan.
Hitoshi HashimotoiPS Cell-based Research Project on Brain Neuropharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita 565-0871, Japan.ORCID http://orcid.org/0000-0001-6548-4016
Masahiko WatanabeDepartment of Anatomy, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
Toshiya ManabeDivision of Neuronal Network, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Tadashi YamamotoDivision of Oncology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Masatoshi TakedaDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Masanobu KanoDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
The University of Osaka · JPThe University of Tokyo · JPHokkaido University · JPTokyo Metropolitan Institute of Medical Science · JPWaseda University · JPFujita Health University · JPJuntendo University · JPNagoya University · JPOkinawa Institute of Science and Technology Graduate University · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracellular trafficking of receptor proteins is essential for neurons to detect various extracellular factors during the formation and refinement of neural circuits. However, the precise mechanisms underlying the trafficking of neurotrophin receptors to synapses remain elusive. Here, we demonstrate that a brain-enriched sorting nexin, ARHGAP33, is a new type of regulator for the intracellular trafficking of TrkB, a high-affinity receptor for brain-derived neurotrophic factor. ARHGAP33 knockout (KO) mice exhibit reduced expression of synaptic TrkB, impaired spine development and neuropsychiatric disorder-related behavioural abnormalities. These deficits are rescued by specific pharmacological enhancement of TrkB signalling in ARHGAP33 KO mice. Mechanistically, ARHGAP33 interacts with SORT1 to cooperatively regulate TrkB trafficking. Human ARHGAP33 is associated with brain phenotypes and reduced SORT1 expression is found in patients with schizophrenia. We propose that ARHGAP33/SORT1-mediated TrkB trafficking is essential for synapse development and that the dysfunction of this mechanism may be a new molecular pathology of neuropsychiatric disorders.

Indexed as

Behavior, AnimalAdaptor Proteins, Vesicular TransportAdultAnimalsBrainCase-Control StudiesCells, CulturedDendritic SpinesFemaleGTPase-Activating ProteinsHEK293 CellsHippocampusHumansImmunoblottingImmunohistochemistryIn Situ HybridizationAdaptor Proteins, Vesicular TransportARHGAP33 protein, humanGTPase-Activating ProteinsReceptor, trkBRNA, MessengerSNX26 protein, mouseSortilinSorting Nexins

Identifiers

PMID26839058
PMCPMC4742909
OpenAlexW2337461628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.